Analysis and significance of the malignant 'Eclipse' during the progression of primary cutaneous human melanomas

Journal of Investigative Dermatology Symposium Proceedings

Volumn 1, Issue 2, 1996, Pages 183-187

  Kerbel, Robert S ^a  

^a SUNNYBROOK RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; APOPTOSIS; ARTICLE; CANCER STAGING; CELL CULTURE; HUMAN; MELANOMA; MOUSE; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; SKIN TUMOR; VASCULARIZATION;

ANIMALS; APOPTOSIS; HUMANS; MELANOMA; MICE; NEOPLASM STAGING; NEOVASCULARIZATION, PATHOLOGIC; SKIN NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 0030112257     PISSN: 10870024     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Albcda SM, Mette SA. Edler DA, Stcwart R, Damjanovich L, Herlyii M, Buck GA: Integrin distribution in malignant melanoma: association of the β3 subunit with tumor progression. Cancer Res 50:6757-6764, 1990
2. Bani MR, Rak J, Adachi I), Kerbel RS, Ben-David Y: Malignant conversion of an early stage human melanoma induced by inscrtional mutagcnesîs mimics natural disease progression. Oiifvgcne submitted: 1995
3. lïonfil Rl>, Vinyals A. liustuoabad 01), Llorens A, Benavides FJ, Gonzalez-Garrigues M, Fabra A: Stimulation of angiogencsis as an explanation of Matrigel-enhanced lumorigenicity. IntJ Caixer 58:233-239, 1994
4. Cascinclli N, Bufalino R, Morabito A, Mackie R: Results of adjuvant Interferon therapy in WHO melanoma programme (letter). Laufet 343:913-914, 1994
5. Clark W: Tumor progression and the nature of cancer. RrJ Canter 64:631-644, 1991
6. oniil I, Theodorescu H, Man S, Hcrlyn M, Jambrosic J, Kerbel RS: Fibroblast cell interactions with human melanoma cells affect tumor cell growth as a function of tumor progression, /'nv Xail AfaJ Sci USA 88:6028-6032, 1991
7. de Vrics TJ, Quax PUA, Denijn M. Vcrrijo KM, Verhcijen JH, Vcrspagct HW, Van Muijen GNP: Plasmînogcii activators, their inhibitors, and urokiiiasc receptor emerge in late stages of melanoc) tic tumor progression. AntJ Paihcti 144:70-81, 1994
8. Folkman J: What is the role of angiogciiesis in metastasis from cutaneous melanoma? EurJ Cancer Clin One! 23:361-363, 1987
9. Graham CH, lUvers J, Kerbel RS, Stankiewicz KS, White WL: Extent of vascularization as an independent prognostic indicator in thin (0.76 mm) malignant melanomas. AmJPathol 145:510-514, 1994
10. Halaban R, Kwon 15, Ghosh S, Dclli Bovis P, Baird A: bFGF as an autocrine growth factor for human mclanocytcs. Oncogcne Res 3:177-186, 1988
11. Herlyn M: Human melanoma: development and progression. Cancer Metastasis Ret1 9:101-112, 1990
12. Herlyn M. Balaban G, lîennicelli J, Gucrry D, Halaban R, Herlyn I), Elder OE, Maul GG, Steplewski Z, Nowcll PC, Clark WH. Koprowski H: Primär)- melanoma cells of the vertical growth phase: similarities to mctastatic cells. J Natl Cancer Inst 74:283-289, 1985
13. Herlyii M, Kath R, Williams N, Valyi-Nagy I, Rodeck U: Growth regulator)1 factors for normal, prcmalignant, and malignant human cells IK vitro. Adv Cancer Res 54:213-234, 1989
14. Holmgren L, O'Reilly MS, Folkman J: Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression. Mature MeJ 1:149-153, 1995
15. Holzmann 15, Brocker EB, Lehmann J, Ruiter DJ, Sorg C, Rcithmullcr G, Johnson J: Tumor progression in human malignant melanoma: five stages defined by their antigenic phcnotypes. IntJ Cancer 39:446-471, 1987
16. JolmsonJP, Stade BG, Holzmann B, Schwäble N, Rcithmullcr G: De novo expression of intercellular adhesion molecule 1 in melanoma correlates with increased risk of metastasis. Proe Natl Acad Sci USA 86:641-644, 1989
17. Kath R, Rodcck U, Parmitcr A, Hcrlyn M: Growth factor independence in vitro of primary melanoma cells from advanced but not early or intermediate lesions. Cancer Therapy and Control 1:179-191, 1991
18. Kerbel RS: Growth dominance of the mctastatic cancer cell: cellular and molecular aspects. Adv Cancer Res 55:87-132, 1990
19. Kerbel RS, Comil I, Man MS, Ishikawa M: Importance of orthotopic transplantation procedures in assessing the effects of tramfectcd genes on human tumor growth and metastasis. Cancer Metastasis Rev 10:201-215, 1991
20. Kerbel RS, Waghornc C, Korczak B, Lagarde A, Brcitman M: Clonal dominance of primarj' tumors by mctastatic cells: genetic analysis and biological implications. Cancer Surveys 7:597-629, 1988
21. Kobayashi H, Man S, MacDougall JR, Graham CH, Lu C, Kerbel RS: Variant sublines of early-stage human melanomas selected for tumorigenicity in nude mice express a multicytokine resistant phenotype. Am J Pathol 144:776-786, 1994
22. Lehmann JM, Riethmullcr G, Johnson JP: MLJC18, a marker of tumor progression in human melanoma shows sequence similarity to the neural cell adhesion molecules of the immunoglobulin superfamily. J'/w NW Acad Sci USA 330:9891-9895, 1989
23. Lu C, RakJW, Kobayashi H, Kerbel RS: Increased resistance to oncostatin M-induccd growth inhibition of human melanoma cell lines derived from advanced-stage lesions. Cancer Res 53:2708-2711, 1993
24. Lu C, Vickcrs MF, Kerbel RS: Interleukin-6: A fibroblast-derived growth inhibitor of human melanoma cells from early but not advanced stages of tumor progression. /Vor Xatl Acad Sci USA 89:9215-9219, 1992
25. MacDougall J, Kerbel RS: Responstveness of normal/dysplastic mclanocytcs and melanoma cells from different Icsional stages of disease progression to the growth inhibitor)' effects of TGF-J3. Mot Cell Dif 1:21-40, 1993
26. MacDougall JR, Lin Y, RakJ, Kerbel RS: The 92 kDa gclatinasc B is expressed by advanced stage melanoma cells: Suppression by somatic cell hybridization with early stage melanoma cells. Cancer Res 55:4174-4181, 1995
27. 3 rescues melanoma cells from apoptosis in three-dimensional dermal collagen. Pnv Xatl Acad Sci USA 91:8856-8860, 1994
28. Murray C: Tumour dormancy: not so sleepy after all. Mature MeJ 1:117-118, 1995
29. Potgens AJG, Lubsen NH, van Aliéna MC, Schocnmakcrs JGG, Ruiter DJ, de Waal RWW: Vascular permeability factor expression influences tumor angiogenesis in human melanoma lines xcnograftcd to nude mice. AntJ Paihol 146:197-209, 1995
30. Rivers J, Ho VC: Malignant melanoma: who shall live and who shall die? Arch Dtrtnatol 128:537-542, 1992
31. Rodeck U, Beckcr D, Herlyn M: Basic fibroblast growth factor in human melanomas. Cancer Cells 3:308-311, 1991
32. Rodeck U, Hcrlyii M, Mcnsscn HD, Furlanctto RW, Koprowski H: Mctastatic but not primär)- melanoma cell lines grow in vitro independently of exogenous growth factors. IntJ Cancer 40:687-690, 1987
33. Steller H: Apoptosis: mechanisms and genes of cellular suicide. Science 267:1445-1462, 1995
34. Sutherland RM: Cell and environment interactions in tumor microregions: the multicell spheroid model. Science 240:177-184, 1988
35. Vartanian RK, Weidner N: Correlation of intratumoral cndothclial cell proliferation with microvcsscl density (tumor angiogenesis) and tumor cell proliferation in breast carcinoma. Am J Pathol 144:1188-1194, 1994
36. Vukicccvic S, Klincmaii H, Luytcii FP, Roberts AB, Roche NS, Rcddie AH: Identification of multiple active growth factors in basement membrane Matrigel suggests caution in interpretation of cellular activity related to extracellular matrix components. Exp Cell Res 202:1-8, 1992
37. Weidner N, SemplcJP, Welch WR, Folkman J: Tumor angiogenesis and metastasiscorrelation in invasive breast carcinoma. iV EntfJ McJ 324:1-8, 1991
38. White CW, Sondheimer HM, Crouch EC, Wilson H, Fan LL: Treatment of pulmonary heniangiomatosis with recombinant Interferon alfa-2a. N Engl J Med 320:1197, 1988